Treatment for patients with type 3 von Willebrand disease and alloantibodies: a case report.
Franchini
M
M
Gandini
G
G
Giuffrida
A
A
De Gironcoli
M
M
Federici
A B
AB
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced; D000941:Antigens / Q000097:blood; D003029:Coagulants / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007518:Isoantibodies / Q000276:immunology*; D014842:von Willebrand Diseases / Q000188:drug therapy*; D014841:von Willebrand Factor / Q000009:adverse effects
D000941:Antigens; D003029:Coagulants; D007518:Isoantibodies; C029417:Von Willebrand antigen; D014841:von Willebrand Factor; C078147:F8 protein, human; D005169:Factor VIII